TREADWELL THERAPEUTICS
Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer. Founded by a cadre of pre-eminent scientific luminaries, including Dr. Tak W. Mak, the Company's robust, internally developed pipeline includes a first-in-class PLK4 kinase inhibitor, CFI-400945, and a best-in-class TTK inhibitor, CFI-402257, and CFI-402411, an oral immunomodulatory kinase inhibitor with activity toward HPK1. Treadwell also has a robust pre-clinical pipeline with multiple biologic and next-generation TCR-based autologous cell therapy programs.
TREADWELL THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Oncology Therapeutics
Founded:
2020-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.treadwelltx.com
Total Employee:
11+
Status:
Active
Total Funding:
118 M USD
Technology used in webpage:
Euro Cloudflare Hosting Lorem Ipsum
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Chess Therapeutics, LLC
It is an oncology focused biotechnology company developing novel microtubule targeted drugs with distinct spectrum of anti-cancer activity.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Prescient Therapeutics
Prescient Therapeutics is a biopharmaceutical company, discovers and develops novel immunotherapeutic products for the treatment of chronic.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-10-15 | TCRyption | TCRyption acquired by Treadwell Therapeutics | N/A |
Investors List
Alpha Win Capital
Alpha Win Capital investment in Series B - Treadwell Therapeutics
Prosperous Alliance Investments
Prosperous Alliance Investments investment in Series B - Treadwell Therapeutics
3W Fund Management
3W Fund Management investment in Series B - Treadwell Therapeutics
TIO Bioventures
TIO Bioventures investment in Series B - Treadwell Therapeutics
Sino Biopharmaceutical
Sino Biopharmaceutical investment in Series B - Treadwell Therapeutics
Adrian Cheng
Adrian Cheng investment in Series B - Treadwell Therapeutics
Fortune Ocean Growth Fund
Fortune Ocean Growth Fund investment in Series B - Treadwell Therapeutics
Key Employee Changes
Official Site Inspections
http://www.treadwelltx.com Semrush global rank: 7.88 M Semrush visits lastest month: 679
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Treadwell Therapeutics"
About | Treadwell Therapeutics
Apr 24, 2024 We believe one solution rests in pursuing scientific areas that remain underexplored and underappreciated. Forging new ground in healthcare requires venturing …See details»
Treadwell Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
May 7, 2025 Treadwell also has a broad pre-clinical pipeline with multiple biologic and next generation TCR based autologous cell therapy programs. For more information, please visit …See details»
Treadwell Therapeutics, Inc. Information - RocketReach
Treadwell Therapeutics, Inc. is a Biotechnology Research, Business Services General, and Biotechnology company located in New York, New York with 28 employees. Find top …See details»
Treadwell Therapeutics - Crunchbase Company Profile & Funding
Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.See details»
Treadwell Company Profile | Management and Employees List
Find contact information for Treadwell. Learn about their Research & Development, Business Services market share, competitors, and Treadwell's email format.See details»
Treadwell - 2025 Company Profile & Team - Tracxn
Jun 11, 2025 Treadwell develops therapeutics for cancer. The company's products pipeline includes CFI-400945 which is an orally active small molecule drug that selectively inhibits …See details»
Treadwell - Overview, News & Similar companies | ZoomInfo.com
Feb 3, 2023 View Treadwell (www.treadwelltx.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Treadwell Therapeutics
Treadwell Therapeutics is developing novel therapeutics to treat highly aggressive cancers. Building upon work uncovered from their scientific co-founders, Treadwell is focused on drug …See details»
Home | Treadwell Therapeutics
At Treadwell Therapeutics, we are a clinical stage, multi-modality oncology company breaking away from the incremental mold. By pursuing novel targets for therapeutic intervention and …See details»
Treadwell Therapeutics - LifeScienceHistory.com
Treadwell Therapeutics is a clinical-stage biotechnology company developing novel therapeutics for highly aggressive cancers by targeting critical tumor-specific vulnerabilities including …See details»
Treadwell Therapeutics, Inc. - Company Profile & Staff Directory ...
Treadwell Therapeutics, Inc. is a Biotechnology company located in New York, NY, US with 46 employees. Access Treadwell Therapeutics, Inc.'s email format and Treadwell Therapeutics, …See details»
Treadwell Therapeutics: Revenue, Worth, Valuation & Competitors …
About Treadwell Therapeutics Treadwell Therapeutics is a Biotech related company founded in 2019 and based in New York City with 56 employees an estimated revenue of $4.3M, and. It …See details»
Treadwell Therapeutics Announces The Closing of a $91 Million …
Nov 18, 2021 “Our team is very excited to announce the closing of this transformative Series B financing, and are very grateful to our investors, both old and new, for their belief, commitment …See details»
Treadwell Therapeutics Announces the Appointment of Roger …
Feb 3, 2023 /CNW/ -- Treadwell Therapeutics, a clinical-stage, global biotechnology company developing novel, first in class therapeutics for highly aggressive cancers,...See details»
Treadwell Announces Strategic Pipeline Prioritization and …
Dec 6, 2023 – Treadwell to focus on advancing first-in-class PLK4 inhibitor CFI-400945 in AML towards potential pivotal studies in 2025 – Approximately 30% reduction in workforce to …See details»
Treadwell Therapeutics, Inc. Management Team | Org Chart
Treadwell Therapeutics, Inc. employs 19 employees. The Treadwell Therapeutics, Inc. management team includes Bob Bennett (Senior Vice President, Business Development), …See details»
Treadwell Announces Strategic Pipeline Prioritization and …
Dec 7, 2023 Treadwell also has a broad pre-clinical pipeline with multiple biologic and next generation TCR based autologous cell therapy programs. For more information, please visit …See details»
Treadwell Therapeutics Announces The Closing of a $91 Million …
Nov 18, 2021 Treadwell Therapeutics Announces The Closing of a $91 Million Series B Financing Proceeds will fund the continued clinical development of CFI-400945, CFI-402257 …See details»
Treadwell Therapeutics Announces The Closing of a $91
Nov 18, 2021 Treadwell Therapeutics Announces The Closing of a $91 Million Series B Financing Proceeds will fund the continued clinical development of CFI-400945, CFI-402257 …See details»
Treadwell Therapeutics Announces the Appointment of J.D.
Apr 19, 2022 “The opportunity to join an organization that brings together all of my past experiences alongside such amazing vision, leadership, and devotion to the patient is a dream …See details»